Aveanna Healthcare Holdings Inc. revised revenue guidance for the full Year 2024. For the year, Revenue of greater than $1,970 million, updated from prior guidance of revenue of between $1,960 million and $1,980 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.77 USD | -1.77% | +4.53% | +3.36% |
05-13 | UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating | MT |
05-09 | Transcript : Aveanna Healthcare Holdings Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.36% | 543M | |
+17.13% | 83.4B | |
-27.75% | 72.11B | |
0.00% | 27.04B | |
-11.96% | 16.96B | |
+0.21% | 16.86B | |
+2.81% | 15.76B | |
+73.85% | 13.33B | |
+1.53% | 12.76B | |
+71.60% | 12.74B |
- Stock Market
- Equities
- AVAH Stock
- News Aveanna Healthcare Holdings Inc.
- Aveanna Healthcare Holdings Inc. Revises Revenue Guidance for the Full Year 2024